IMPORTANCE Hypertension control for large populations remains a major challenge.
H ypertension affects 65 million adults in the United States (29%) 1 and is a major contributor to cardiovascular disease. 2 Although effective therapies have been available for more than 50 years, 3 fewer than half of Americans with hypertension had controlled blood pressure in [2001] [2002] . 1 Many quality improvement strategies for control of hypertension exist, 4-10 but to date, no successful, large-scale program sustained over a long period has been described. A review of 72 clinical trials 11 identified several interventions that improve blood pressure control in primary care settings, with the stronge s t e v i d e n c e f o r a n organized, comprehensive system of regular population review and intervention. Kaiser Permanente Northern California (KPNC) is a not-forprofit, integrated health care delivery system caring for more than 2.3 million adult members, with comprehensive inpatient and outpatient care provided through 21 hospitals, 45 medical facilities, and more than 7000 physicians. In 2001, KPNC developed a system-level, multifaceted quality improvement program for hypertension. We describe the details of the development and implementation of this program and its associated results for the period between [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] .
Methods

KPNC Hypertension Program
The study was exempted from review by the Kaiser Foundation Research Institute's institutional review board. The KPNC hypertension quality improvement program included 5 major components.
Health System-Wide Hypertension Registry
In 2000, KPNC developed a large-scale program to improve blood pressure control. Patients with hypertension were identified quarterly using outpatient diagnostic codes, pharmacy data, and hospitalization records from health plan databases, and diagnoses were verified through chart review audits of random samples of identified members. Patients were included if they met any of the following: (1) 2 or more hypertension diagnoses coded in primary care visits in the prior 2 years, (2) 1 or more primary care hypertension diagnoses and 1 or more hospitalizations with a primary or secondary hypertension diagnosis in the prior 2 years, (3) 1 or more primary care hypertension diagnoses and 1 or more filled prescriptions for hypertension medication within the prior 6 months, or (4) 1 or more primary care hypertension diagnoses and 1 or more stroke-related hospitalizations or a history of coronary disease, heart failure, or diabetes mellitus. Per National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) specifications, patients were not included based on recorded blood pressure measurements alone. If no blood pressure was recorded during the measurement year, the patient was classified as "not controlled." In 2001, internal hypertension control reports were developed for quality improvement use, and performance measurements were designed that were similar to those of the NCQA HEDIS metric described above. However, unlike the NCQA HEDIS measurement, which included only a random sample of eligible individuals, the internal metric included all KPNC patients eligible for inclusion in the NQCA HEDIS hypertension control metric, ie, continuously enrolled members aged 18 to 85 years (46-85 years before 2006) as of December 31 of the measurement year, with documented hypertension in the medical record on or before June 30 of the measurement year. Patients were excluded from the internal hypertension control metric using the same criteria as the NCQA HEDIS commercial metric.
Hypertension control reports were generated every 1 to 3 months for each KPNC medical center and distributed to the center directors. During the study period, a central hypertension management team identified successful practices and disseminated effective strategies to the medical centers.
Development of an Evidence-Based Practice Guideline
In 2001, an evidence-based, 4-step hypertension control algorithm was developed to aid clinicians ( Table 1 ). The guideline was updated every 2 years based on emerging randomized trial evidence and national guidelines. Clinicians were encouraged to follow the algorithm unless clinical discretion required otherwise. Dissemination of guidelines occurred through distribution of printed documents, e-mail, clinical tools (eg, pocket cards), videoconferences, lectures, partnering with pharmacy managers, and use of the electronic medical record to optimize selection of medication.
Medical Assistant Visits for Follow-up Measurements
In 2007, all medical centers developed a medical assistant follow-up visit typically scheduled 2 to 4 weeks after a medication adjustment. Typically, a medical assistant measured blood pressure and informed the primary care physician, who then directed treatment decisions and follow-up planning. Medical assistants were trained using standardized materials and blood pressure competency assessments. Patients were not charged a co-payment for these visits. This system accelerated treatment intensification without significantly increasing the need for repeat clinician visits, while simultaneously improving patient convenience and affordability.
Promotion of Single-Pill Combination Therapy
In 2005, single-pill combination (SPC) therapy with lisinoprilhydrochlorothiazide was incorporated into the regional guideline as being optional for initial treatment and recommended as a step-2 strategy (Table 1) .
Patient Characteristics
Information on demographic characteristics was available for patients in the hypertension registry ( Table 2 ). Diabetes melli- tus was ascertained from a regional diabetes registry (see Appendix [Supplement] for details). 13 
Hypertension Control Rates
Control rate was defined as meeting the NCQA HEDIS commercial hypertension control criteria, an externally reported standard that permits comparison of rates across reporting health plans. 12 Using the same method, we report on KPNC hypertension registry control rates during the study period. We also examined publicly available national and California state commercial NCQA HEDIS control rates. 12 California data represented the mean control rate of commercial health insurance plans.
Statistical Analysis
Analyses were performed using SAS version 9. Figure 1A) . Control rates calculated using the NCQA HEDIS metric and internal hypertension registry control metric were similar (P < .001 for trend) ( Figure 1B) . In contrast, the national mean NCQA HEDIS control rate increased from 55.4% to 64.1% between 2001 and 2009 (P = .24 for trend). Californiawide control rates were available since 2006 and were similar but slightly higher than the national average (63.4% vs 69.4% from 2006 to 2009; P = .37 for trend).
In addition, following the study period, the NCQA HEDIS hypertension control rate within KPNC continued to improve, from 83.7% in 2010 to 87.1% in 2011.
From 2001 to 2009, the rate of lisinopril-hydrochlorothiazide SPC prescriptions in KPNC increased from 13 to 23 144 prescriptions per month. During this period, the percentage of angiotensin-converting enzyme (ACE) inhibitor prescriptions dispensed as an SPC (in combination with a thiazide diuretic) increased from less than 1% to 27.2% ( Figure 2 ).
Discussion
Control of hypertension remains elusive nationally, despite widespread availability of effective therapies. Furthermore, limited data exist about the implementation and results of large, sustained hypertension programs. We describe a multifactorial approach implemented in one of the nation's largest community-based hypertension programs. This approach was associated with a near-doubling of hypertension control Our study is observational, and several facets of the hypertension program may have contributed to the improved hypertension control within our population. Creation of a comprehensive hypertension registry facilitated customizable queries to access clinically important dataenabled prioritization of patient subgroups (eg, poorly controlled hypertension) who were evaluated for appropriateness of treatment intensification. This is consistent with observations by Glynn et al, 11 who reported that the most effective intervention to improve blood pressure control in primary care settings is an organized system of regular population review rather than primarily patient-or clinician-focused interventions.
Regularly scheduled performance feedback delivered through quarterly and eventually monthly reports facilitated identification of high-performing medical centers in which successful practices or innovations were identified and then disseminated program-wide. Although feedback at the individual clinician level has long been used to promote change, 14 we focused on clinic-level feedback to facilitate operational and system-level change. 15 Health system-wide adoption, evaluation, and distribution of an evidence-based practice guideline that had timely incorporation of new evidence facilitated the ability to introduce new treatment options and to re-emphasize existing evidence-based recommendations. 4, 15, 16 For example, β-blockers historically had an important role in management of hypertension and were an important part of early KPNC practice guidelines. As new evidence became available, the role of β-blockade in uncomplicated hypertension gradually diminished, and KPNC practice guidelines were revised accordingly. Systematic medical assistant follow-up visits were designed to optimize workflow for clinicians while leveraging the skills of ancillary staff. These visits allowed patients greater access to the medical team by eliminating co-payments, allowing greater scheduling flexibility, and involving shorter visit times, all of which reduced patient barriers.
4,17
Use of lisinopril-hydrochlorothiazide SPC therapy was incorporated into KPNC practice guidelines in 2005, with subsequent rapid uptake system-wide. Single-pill combinations have important advantages, including improved adherence 18, 19 and lower patient cost, 19 and are associated with improved blood pressure control. 15, [20] [21] [22] It is not clear why in 2001 the NCQA HEDIS commercial control rate (43.6%) within KPNC was lower than the national control rate (55.4%). Possible explanations include lower actual control rates or underdiagnosis of milder disease. Also, because patients without a recorded blood pressure during the measurement year were considered as having uncontrolled hypertension, it may be that the portion of patients without a recorded blood pressure decreased during the study period. Because the KPNC hypertension registry increased from 15.4% to 27.5% of the KPNC adult population during the study period, it is possible that the severity of hypertension within the registry decreased, although the prevalence was similar to that seen in the National Health and Nutrition Examination Survey (NHANES) (29.0%) in [2007] [2008] . 1 Furthermore, during the same period, the number of prescriptions per month for the most commonly used antihypertensive medications (ie, thiazide diuretics, ACE inhibitors, angiotensin receptor blockers, β-blockers, calcium channel blockers, and ACE inhibitors-thiazide diuretics as SPCs) increased in KPNC by 82%. Collectively, these data suggest that the apparent increase in hypertension reflects primarily improved detection and documentation of hypertension.
Comparison of demographic characteristics between patients used to determine the NCQA HEDIS control rates within KPNC and national or statewide NCQA HEDIS measures were not presented, because demographic NCQA HEDIS data from other health plans were not publicly reported. Although survey data were available and reviewed from California (California Health Interview Survey [CHIS] ) and national (NHANES) sources, key methodological data acquisition differences precluded direct comparisons. KPNC data were collected for insured members using objective data documented in medical records. In contrast, NHANES and CHIS survey data were collected from volunteers with and without health insurance, which may influence the sociodemographic composition of respondents, and relied on self-report to identify the presence of diabetes (NHANES and CHIS) and diagnosed hypertension (CHIS), with attendant concerns about significant misclassification contributing to apparent variation in prevalence of comorbid conditions. Census data from 2011 indicate that, compared with the nation, California residents were slightly younger, more likely to be Hispanic and Asian, and less likely to be white or black but had similar sex distribution. 23 However, these differences are unlikely to explain the large differences between KPNC control rates compared with California and national rates, because both the state and national average NCQA HEDIS control rates were similar and the KPNC population is highly representative of the statewide population, except for slightly lower representation at the extremes of age and income. 24, 25 Comparisons of KPNC control rates with those from NHANES are also limited because of differences in the definition of controlled hypertension. KPNC rates were determined based on the standard NCQA HEDIS protocol using the most recent recorded outpatient blood pressure, which was the lowest recorded measurement on the day of examination, usually measured by a trained medical assistant using an automated sphygmomanometer. NHANES defined hypertension control based on blood pressure data measured by clinicians using mercury sphygmomanometers at a mobile examination center (using the mean of up to 3 blood pressure measurements during a single examination). Comparison of KPNC control rates with CHIS-derived California control rates is not possible because hypertension control was not a component of the CHIS survey. 26 Last, although patients with end-stage renal disease were excluded from the KPNC hypertension registry and control denominator in accordance with the NCQA HEDIS methodology, these patients comprised only 0.37% of the KPNC population, so the effects on overall hypertension control measures would be minimal. In this observational study of a multifaceted intervention program, we cannot determine the degree to which individual components contributed to improved hypertension control or the role of other unidentified factors. Using the NCQA HEDIS commercial methodology facilitated comparisons against national and state estimates, but given that this approach relies on data from only a small subset of the overall hypertensive population, variations in year-to-year control estimates could be attributable to fluctuations in random sampling. The NCQA HEDIS commercial control rate is used nationally to compare hypertension control across health care organizations, so we cannot directly compare control rates from our larger internal hypertension registry with rates from other health care delivery systems. However, our internal hypertension registry control rates were very similar to our externally reported NCQA HEDIS commercial control rates, with the rates increasing similarly over time ( Figure 1B ). Our study extends reports from other large health care delivery systems that have also observed significant improvement in hypertension control. For example, the Veterans Affairs health care system reported improvements in hypertension control rates from 75% to 77% between 2006 and 2009. [27] [28] [29] In summary, implementation of a large-scale hypertension program was associated with improvements in hypertension control rates between 2001 and 2009 . Key elements of the program include establishment of a comprehensive hypertension registry, development and sharing of performance metrics, evidence-based guidelines, medical assistant visits for blood pressure measurement, and SPC pharmacotherapy.
